MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
18.50
+0.27 (1.48%)
May 27, 2026, 10:51 AM EDT - Market open

MLTX Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
298.49334.52180.43451.1739.518.04
Short-Term Investments
59.4359.45267.659.8432.61-
Cash & Short-Term Investments
357.92393.97448.03511.0172.118.04
Cash Growth
-25.45%-12.07%-12.32%608.60%797.08%501.75%
Other Receivables
5.764.872.841.060.220.15
Total Trade Receivables
5.764.872.841.060.220.15
Other Current Assets
32.9622.8623.422.14.181.45
Total Current Assets
396.64421.69474.29514.1776.519.64
Net Property, Plant & Equipment
2.392.143.643.950.330.05
Other Long-Term Assets
1.340.6-8.42--
Total Assets
400.37424.43477.93526.5476.849.68
Accounts Payable
23.3829.558.991.840.25-
Accrued Expenses
21.8114.6912.16.937.264.52
Short-Term Debt
-----15
Current Portion of Leases
0.921.231.371.20.15-
Total Current Liabilities
46.1145.4822.469.977.6721.09
Long-Term Debt
99.0274.1----
Long-Term Leases
0.870.371.462.50.13-
Other Long-Term Liabilities
0.35-0.620.580.280.24
Total Long-Term Liabilities
100.2474.472.083.080.410.24
Total Liabilities
146.35119.9524.5413.058.0821.33
Preferred Stock
-----0.07
Common Stock
0.010.010.010.010.010.04
Treasury Stock
------0.01
Additional Paid-in Capital
786.31766.78677.42609.97129.1942.06
Accumulated Other Comprehensive Income
0.320.652.360.35-0.17
Retained Earnings
-532.62-462.91-235.59-116.66-80.65-
Total Common Shareholders' Equity
254.02304.48446.83495.6848.942
Minority Interest
--6.5717.8219.87-
Shareholders' Equity
254.02304.48453.39513.4968.7742
Total Liabilities & Equity
400.37424.43477.93526.5476.849.68
Total Debt
100.875.712.833.70.2815
Net Cash (Debt)
257.12318.26445.2507.3171.83-6.96
Net Cash Growth
-19.21%-28.51%-12.24%606.24%--
Net Cash Per Share
3.864.947.0810.331.89-0.65
Book Value
254.02304.48446.83495.6848.942
Book Value Per Share
3.824.727.1110.091.293.91
Tangible Book Value
254.02304.48446.83495.6848.942
Tangible Book Value Per Share
3.824.727.1110.091.293.91
Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q